| Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
|---|
| 07/23/2003 | CN1431904A Protease inhitors |
| 07/22/2003 | US6596876 Prostaglandin I2 inhibitors |
| 07/22/2003 | US6596875 Method for synthesizing epothilones and epothilone analogs |
| 07/22/2003 | US6596873 2-and 2,5-substituted phenylketoenols |
| 07/22/2003 | US6596747 For therapy of diseases associdated with Factor VIIa and or inosine monophosphate dehydrogenase (IMPDH) |
| 07/22/2003 | US6596746 Cyclic protein tyrosine kinase inhibitors |
| 07/22/2003 | US6596745 Method for treating fibrotic diseases with azolium chroman compounds |
| 07/22/2003 | US6596744 Method for treating fibrotic diseases or other indications IIC |
| 07/22/2003 | US6596738 Inhibiting activity to adenosine deaminase (hereinafter described as ADA) An adenosine deaminase inhibiting agent comprising a compound of the formula (I): |
| 07/22/2003 | US6596728 A pharmaceutical composition, comprising at least one compound or salt thereof as claimed in claim 1 and a polypeptides with excipients |
| 07/22/2003 | US6596724 Oxadiazole and thiadiazole derivatives of dihydropyridine NPY antagonists |
| 07/22/2003 | US6596723 Fungal efflux pump inhibitors |
| 07/22/2003 | US6596718 7-Morpholin-4yl-benzothiazole amide derivatives |
| 07/22/2003 | CA2228572C Nk-1 receptor antagonists for prevention of neurogenic inflammation in gene therapy |
| 07/17/2003 | WO2003057693A1 5-membered cyclic compounds |
| 07/17/2003 | WO2003057692A1 Novel crystalline forms of meloxicam and the preparation and interconversion methods thereof |
| 07/17/2003 | WO2003057676A1 3,4-di-substituted pyridazinediones as cxc chemokine receptor antagonists |
| 07/17/2003 | WO2003057674A1 4-sulfide / sulfoxide / sulfonyl-1h-pyrazolyl derivative compounds, for use in diseases associated with the 5-ht2c receptor |
| 07/17/2003 | WO2003057672A2 Tetrahydroquinoline analogues as muscarinic agonists |
| 07/17/2003 | WO2003057669A1 Androgen receptor antagonists |
| 07/17/2003 | WO2003057668A1 Nitrogenous cyclic ketone derivative, process for producing the same, and use |
| 07/17/2003 | WO2003057666A2 Inhibitors of dipeptidyl peptidase iv |
| 07/17/2003 | WO2003057144A2 Change inhibitors of dipeptidyl peptidase iv |
| 07/17/2003 | WO2002055496A8 Aryl piperidine and piperazine derivatives as inducers of ldl-receptor expression |
| 07/17/2003 | WO2002006280A3 INHIBITORS OF FACTOR Xa |
| 07/17/2003 | US20030135057 5-amino- and 5-thio- substituted; prepared from a methylenedithietane intermediate |
| 07/17/2003 | US20030134888 Substituted diaminopyrazoles; treating diseases, such as cancer, inflammatory disorders, restenosis, and cardiovascular disease. coatings for implantable medical devices, such as prostheses, artificial valves, etc. |
| 07/17/2003 | US20030134885 Biaromatic ligand activators of PPARgamma receptors |
| 07/17/2003 | US20030134883 Use in the treatment of cancer and other diseases characterized by undesired cellular hyperproliferation. |
| 07/17/2003 | US20030134876 Inhibiting TNF alpha |
| 07/17/2003 | US20030134859 Substituted 2-chloro-5-nitrobenzamides; treating retrograde osteoporosis and diabetes mellitus |
| 07/17/2003 | US20030134855 P-acylaminomethyl-N-(4-methoxy-7-morpholin-4-yl-benzothiazol-2 -yl)-benzamides; treatment of diseases related to the adenosine receptor, such as Alzheimer's disease, depression, drug addiction, Parkinson's and ADHD |
| 07/17/2003 | US20030134854 Treatment of diseases related to the adenosine receptor, such as Alzheimer's disease, depression, drug addiction, neuroprotection, Parkinson's disease, and attention deficit hyperactivity disorder. |
| 07/17/2003 | US20030134849 Thiazepinyl hydroxamic acid derivatives as matrix metalloproteinase inhibitors |
| 07/17/2003 | US20030134848 Substituted 1-aza-2-imino-heterocycles and their use as nicotinic acetylcholin receptors activators |
| 07/17/2003 | US20030134840 Novel compounds |
| 07/17/2003 | US20030134836 Substituted arylamine derivatives and methods of use |
| 07/17/2003 | US20030134827 Lactams or pharmaceutically acceptable salt forms thereof, wherein rings ring B is a 4-8 membered cyclic amide containing from 0-3 additional heteroatoms selected from N, O, and S, which are useful as metalloprotease inhibitors. |
| 07/17/2003 | US20030134802 Novel effectors of dipepetidyl peptidase IV |
| 07/17/2003 | US20030134801 Pharmaceutical compositions containing them are of the class of thrombin inhibitors which are useful as anticoagulants. |
| 07/17/2003 | US20030134237 Methine dyes, manufacturing methods thereof, and silver halide photoraphic materials contaning same dyes |
| 07/17/2003 | US20030134148 Red fluorescent dyes having high fluorescent strength and high color purity; high luminance; high efficacy by low voltage-driving; stability; durability; color conversion filter, pulp dyeing; photographic dye; sensitizers |
| 07/17/2003 | CA2472165A1 3,4-di-substituted pyridazinediones as cxc chemokine receptor antagonists |
| 07/17/2003 | CA2471885A1 4-sulfide / sulfoxide / sulfonyl-1h-pyrazolyl derivative compounds, for use in diseases associated with the 5-ht2c receptor |
| 07/17/2003 | CA2471754A1 Androgen receptor antagonist |
| 07/17/2003 | CA2471204A1 Inhibitors of dipeptidyl peptidase iv |
| 07/17/2003 | CA2470164A1 New crystalline forms of meloxicam and processes for their preparation and interconversion. |
| 07/16/2003 | EP1326864A2 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 07/16/2003 | EP1326861A1 Alpha-aryl ethanolamines and their use as beta-3 adrenergic receptor agonists |
| 07/16/2003 | EP1326860A1 Quinazoline derivatives |
| 07/16/2003 | EP1326858A2 Piperidine compounds as anti-allergic |
| 07/16/2003 | EP1326853A1 New thiadiazoles and oxadiazoles and their use as phosphodiesterase-7 inhibitors |
| 07/16/2003 | EP1326852A1 Aromatic and heterocyclic thiazolyl thiourea compounds and use |
| 07/16/2003 | EP1326850A1 A process for the preparation of bis-benzazolyl compounds |
| 07/16/2003 | EP1326829A2 17-beta-hydroxysteroid dehydrogenase-ii inhibitors |
| 07/16/2003 | EP1326606A2 Ep4 receptor inhibitors to treat rheumatoid arthritis |
| 07/16/2003 | EP1175416B1 Heteroaryl diazacycloalkanes, their preparation and use |
| 07/16/2003 | EP1028955B1 Pyrimidinone compounds and pharmaceutical compositions containing them |
| 07/16/2003 | EP0832076B1 Novel isoxazoline and isoxazole fibrinogen receptor antagonists |
| 07/16/2003 | CN1430615A Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 07/16/2003 | CN1430614A Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 07/16/2003 | CN1430612A Hete rocyclic derivatives |
| 07/16/2003 | CN1430610A Substituted 1-aminoalkyl-lactams compound and their use as muscarinic receptor antagonists |
| 07/16/2003 | CN1430609A Substituted 1-aminoalkyl-lactams compound and their use as muscarinic receptor antagonists |
| 07/16/2003 | CN1430608A Substituted iminoazines |
| 07/16/2003 | CN1114604C Bicyclic aryl carboxamides and their therapeutic use |
| 07/16/2003 | CN1114603C Hydrazono-1,3-dithiocyclopentane derivative and synthesizing method thereof |
| 07/16/2003 | CN1114598C Aromatic compounds and pharmaceutical compositions containing them |
| 07/16/2003 | CN1114403C Vitronectin receptor antagonists |
| 07/16/2003 | CN1114402C Isothiazolones compound, preparation containing them and its use |
| 07/15/2003 | USRE38188 Ethylene derivatives and pesticides containing said derivatives |
| 07/15/2003 | US6593472 NK-1 receptor active amine oxide prodrugs |
| 07/15/2003 | US6593357 Treating disease states in mammals that are alleviated by a protein kinase inhibitor, particularly diseases such as cancer, inflammatory disorders, restenosis, and cardiovascular disease. |
| 07/15/2003 | US6593346 Substituted 3-(piperidin-1-ylmethyl)cyclopentylamines, useful as modulators of the chemokine receptors CCR-5 and/or CC R-3. |
| 07/15/2003 | US6593344 These substances have especially high cytostatic activities and pronounced immunosuppressive properties which make them suitable for therapeutic treatment in broad tumor spectrum and autoimmune diseases |
| 07/15/2003 | US6593327 Compounds and compositions as protease inhibitors |
| 07/15/2003 | US6593326 Useful as anti-cancer agents; and processes for their manufacture and pharmaceutical compositions containing them are described. Apoptotic effect in a warm-blooded animal such as man. |
| 07/15/2003 | US6593322 Compounds and methods for modulation of estrogen receptors |
| 07/15/2003 | US6593013 Electroluminescence device, cyclic azine compound and production process of cyclic azine dye |
| 07/15/2003 | US6592633 Less selective colorations and which are particularly resistant to the various attacking factors to which the hair may be subjected |
| 07/10/2003 | WO2003055868A1 Benzothiazole- and benzoxazole-4,7-dione derivatives and their use as cdc25 phosphatase inhibitors |
| 07/10/2003 | WO2003055867A1 Biphenylmethyl-thiazolidinediones and analogues and their use as ppar-gamma activators |
| 07/10/2003 | WO2003055866A1 Quinazoline and quinoline derivative compounds as inhibitors of prolylpeptidase, inducers of apoptosis and cancer treatment agents |
| 07/10/2003 | WO2003055860A1 3,4-diarylpyrazoles and their use in the therapy of cancer |
| 07/10/2003 | WO2003055482A1 Amide derivatives as gk activators |
| 07/10/2003 | WO2003055478A1 Glyt1 transporter inhibitors and uses thereof in treatment of neurological and neuropsychiatric disorders |
| 07/10/2003 | WO2003055447A2 Heterocyclic acridone inhibitors of impdh enzyme |
| 07/10/2003 | WO2003010140A3 Hepatitis c virus polymerase inhibitors with heterobicyclic structure |
| 07/10/2003 | WO2003006440A8 Amide-containing compound having improved solubility and method of improving the solubility of an amide-containing compound |
| 07/10/2003 | WO2001098269A3 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 07/10/2003 | WO2001096297A3 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis |
| 07/10/2003 | US20030130520 Producing substituted 2-nitro-guanidine derivatives. |
| 07/10/2003 | US20030130515 Aryl or heteroaryl substituted 3,4-dihydroanthracene and aryl or heteroaryl substituted benzo[1,2-g]-chrom-3-ene, benzo[1,2-g]-thiochrom-3-ene and benzo [1,2-g]-1,2-dihydroquinoline derivatives having retinoid antagonist or retinoid inverse agonist type biological activity |
| 07/10/2003 | US20030130506 4-phenoxy or 4-(pyrid-4-yloxy)- benzensulfonic acid derivatives; antitumor and antiarthritic agents |
| 07/10/2003 | US20030130505 Nonsteroidal agonists and antagonists |
| 07/10/2003 | US20030130340 Novel benzothiophene derivatives |
| 07/10/2003 | US20030130318 2-sulfonamido-thiazole derivatives |
| 07/10/2003 | US20030130289 Inhibitors of glycogen synthase kinase 3 |
| 07/10/2003 | US20030130287 Psychological disorders; central nervous system disorders; antidepressants; Parkinson's disease; Alzheimer's disease;cardiovascular disorders |
| 07/10/2003 | US20030130282 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |